Design, synthesis, and evaluation of novel oxazolidinone antibacterial agents active against multidrug-resistant bacteria

Advances in Experimental Medicine and Biology

Volumn 456, Issue , 1998, Pages 219-238

  Barbachyn, M R ^a   Brickner, S J ^a   Gadwood, R C ^a   Garmon, S A ^a   Grega, K C ^a   Hutchinson, D K ^a   Munesada, K ^a   Reischer, R J ^a   Taniguchi, M ^a   Thomasco, L M ^a   Toops, D S ^a   Yamada, H ^a   Ford, C W ^a   Zurenko, G E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPEREZOLID; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PNU 100480; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS);

EID: 0032226552     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4897-3_12     Document Type: Review

References (53)

1. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus
2. Synthesis and SAR of novel antibacterial oxazolidinones
3. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity
4. Synthesis and antibacterial activity of new tropone-substituted phenyloxazolidinone antibacterial agents. 2. Modification of the phenyl ring - The potentiating effect of fluorine substitution on in vivo activity
5. Preventing multidrug-resistant tuberculosis
6. Emergence of drug-resistant pneumococcal infections in the United States
7. Oxazolidinone antibacterial agents
8. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections
9. Multicyclic fused-ring oxazolidinone antibacterial agents
10. Antibacterial oxazolidinones: In vitro activity of a new analogue, E3709
11. New approaches to the control of infections caused by antibiotic-resistant bacteria
12. Structure-activity relationships of the fluoroquinolones
13. New directions in antibacterial research
14. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
15. The mechanism of action of DuP 721, a new antibacterial agent: Effects on macromolecular synthesis
16. Mechanism of action of DuP 721: Inhibition of an early event during initiation of protein synthesis
17. In vivo activities of U-100592 and LI-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections
18. 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationships
19. TPAP: Tetra-n-propylammonium perruthenate, a mild and convenient oxidant for alcohols
20. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
21. A mild, osmium tetraoxide-catalyzed method for the oxidation of sulfides to sulfones
22. Activities of two novel oxazolidinones against M. tuberculosis (MTB) in a murine model
23. Periodate oxidation of sulfides to sulfoxides. Scope of the reaction
24. Enterococci acquire new kinds of resistance
25. Resistance to glycopeptides in enterococci
26. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin
27. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
28. Recent perspectives on drug-resistant Streptococcus pneumoniae
29. Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications
30. Methicillin-resistant Staphylococcus aureus as a community organism
31. The quinolones: An overview and comparative appraisal of their pharmacokinetics and pharmacodynamics
32. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
33. Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxazolidinones. 4. Multiply-substituted aryl derivatives
34. Synthesis and antibacterial activity of some novel 1-substituted-7-pyridinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids
35. DuPont's new oxazolidinones
36. Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions
37. Discovery and development of new antibiotics: The problem of antibiotic resistance
38. Activities of RPR 106972 (a new oral streptogramin), ceditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci
39. Linezolid safety, tolerance, and pharmacokinetics following oral dosing twice daily for 14.5 days
40. Linezolid safety, tolerance, and pharmacokinetics after intravenous dosing twice daily for 7.5 days
41. Antibiotic resistance in Streptococcus pneumoniae
42. Multiple-antibiotic-resistant pathogenic bacteria
43. Methicillin-resistant Staphylococcus aureus in Europe
44. Activity of U-100480, an oxazolidinone, against M. avium complex (MAC) infection in beige mice
45. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents